Screener
Beam Therapeutics BEAM Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Beam Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Beam Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:22 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210338
FAQ
- What is Beam Therapeutics's book value per share?
- Beam Therapeutics (BEAM) reported book value per share of $11.28 in Q1 2026.
- How has Beam Therapeutics's book value per share changed year-over-year?
- Beam Therapeutics's book value per share decreased by 12.2% year-over-year, from $12.84 to $11.28.
- What is the long-term trend for Beam Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Beam Therapeutics's book value per share has grown at a 19.0% compound annual growth rate (CAGR), from $5.25 to $12.52.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Beam Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude